News Video | Policy | GPs | Hospitals | Medical | Mental Health | Welfare | Search


Views of NZ self-medication body at odds with safety

25 March 2014

Views of New Zealand self-medication body at odds with safety concerns of some members

AFT Pharmaceuticals (AFT) has identified a major error with the formulation of over 1300 cold and flu products used around the world.

Many over-the-counter (OTC) cold and flu products combine phenylephrine and paracetamol. AFT’s groundbreaking research has revealed that when paracetamol is combined with phenylephrine, the level of phenylephrine is effectively twice what it should be (20mg rather than the standard 10mg level that regulators allow).

The research was recently published in the prestigious New England Journal of Medicine. The discovery has received international attention, including in New Zealand, Australia, China, and the United States.

However, the reaction from the New Zealand Self-Medication Industry Association (NZSMI) has been disappointing. NZSMI acts as the local advocacy body for a number of multinational pharmaceutical companies with OTC operations in New Zealand.

Tim Roper, Executive Director at NZSMI, has been very quick to downplay the discovery. He reportedly told TVNZ that the New England Journal of Medicine publication lacked detail. He also implicitly criticised the integrity of the research because AFT has developed a drug that meets the permitted levels of phenylephrine. Thus, he is reported as saying that “the research done indicated a problem with competitive products but not with the ones that are about to be launched by the company that's involved”.

“These comments are nonsensical in our view,” says Dr Hartley Atkinson, Managing Director of AFT. “The research that underpins the discovery is of the highest standard. If it were anything less, the world’s premier medical journal would not publish it. Furthermore, these results were not from a ‘one off’ experiment. The same results were shown across, not one, but three separate clinical studies. The findings from all of the studies have been made available to the regulators and the additional studies submitted in a major article for publication in medical journals.”

“In addition, any possible implication from the NZSMI that the results may be comprised in some way because AFT has developed the correct formulation of an OTC product also make no sense,” said Dr Atkinson. “First, the New England Journal of Medicine simply would not publish the results if it considered they were tainted by commercial gain. Second, AFT would be failing consumers in New Zealand and around the world if it did not attempt to provide a product that actually delivers the functional 10mg dose of phenylephrine set by the regulators. Consumer safety must always be a cornerstone in the design of any pharmaceutical product, and we stand firmly in that camp.”

Ironically many of the multinational pharmaceutical companies that NZSMI represents argued against increasing the level of phenylephrine above 10mg in their submissions to the US Food and Drug Administration in 20071. The comprehensive 72 page report concluded that “oral phenylephrine 10mg is safe and effective as a nasal decongestant for over-the-counter use in adults” but that “there are insufficient data in adults to support the assertion that increasing the dose of phenylephrine to 25mg is necessary to produce clinically meaningful improvements in nasal decongestion with a similar safety profile as the currently available 10mg OTC monograph dose”.

Dr Atkinson adds, “Here is a discovery that shows combining phenylephrine with paracetamol effectively doubles the amount of phenylephrine in a person’s system – precisely the outcome these multinational pharmaceutical companies did not want, as stated in their submissions to the US Food and Drug Administration. Yet the response of the industry body in New Zealand is to raise doubts about AFT’s on-point research”.

The discovery raises important questions around the safe interaction of phenylephrine with paracetamol. It also raises further questions about the safe interaction between phenylephrine and other ingredients which have not been studied by AFT. For example, ascorbic acid (Vitamin C), which is used in some paracetamol and phenylephrine-based cold and flu remedies, can be expected to further increase the interaction between phenylephrine with paracetamol because of the way such ingredients are metabolized.

“Given the consumer safety imperative, NZSMI should be supportive of all efforts to broaden the knowledge base around possible interactions between phenylephrine and other substances. However, based on Tim Roper’s public comments, it appears this is not the position of NZSMI. I think the general public will be disappointed in this attitude. They will see the Association as ducking for cover on this important issue,” said Dr Atkinson.


© Scoop Media

Culture Headlines | Health Headlines | Education Headlines


13/10: 40 Years Since The Māori Land March Arrived At Parliament

Traffic into Wellington came to a standstill as thousands of Māori and Pākehā streamed along the motorway into the capital on 13 October 1975, concluding the Māori land march to parliament. More>>


Scoop Review Of Books: Before The Quakes

Remembering Christchurch: Voices from decades past: The Christchurch I lived in for my first 23 years was where four-year-olds walked alone to kindergarten, crossing roads empty of all but a couple of cars per hour. My primary school, Ilam, was newly built on a grassy paddock surrounded by rural land... More>>

6-11 October: New Zealand Improvisation Festival Hits Wellington

Wellingtonians will have a wide selection of improv to feast on with a jam packed programme containing 22 shows, three companies from Australia, two companies from Auckland, one from Nelson, one from Christchurch and seven from Wellington. More>>


Bird Of The Year: New Zealanders Asked To Vote For Their Favourite Native Bird

Te Radar, David Farrier, Heather du-Plessis Allan and Duncan Garner are just some of the New Zealanders championing their favourite native bird in Forest & Bird’s annual Bird of the Year competition, which kicks off today.. More>>


Werewolf Film: It Follows - Panic In Detroit

Philip Matthews: When you heard last month that Wes Craven had died and you wanted to pay homage, you could have sat down with any one of five of his films that helped reinvent American horror at least three times over three decades... Or you could just have watched one of the greatest recent horror films that would probably not exist without Craven. More>>


Werewolf Music: Searching For The White Wail - On Art Pepper, etc

If the word ‘hipster’ means anything – which it arguably doesn’t – it seems to be more of an impulse than a condition. One always headed for the margins, and away from the white-bred, white-bread mainstream... More>>


Get More From Scoop



Search Scoop  
Powered by Vodafone
NZ independent news